Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
36.2M
-
Shares change
-
+1.46M
-
Total reported value, excl. options
-
$176M
-
Value change
-
+$2.18M
-
Put/Call ratio
-
1.62
-
Number of buys
-
87
-
Number of sells
-
-68
-
Price
-
$4.86
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q1 2025
197 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q1 2025.
Emergent BioSolutions Inc. - Common Stock (EBS) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.2M shares
of 54.5M outstanding shares and own 66.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.21M shares), MILLENNIUM MANAGEMENT LLC (2.5M shares), AMERICAN CENTURY COMPANIES INC (2.3M shares), BlackRock, Inc. (1.84M shares), STATE STREET CORP (1.71M shares), DIMENSIONAL FUND ADVISORS LP (1.6M shares), MARSHALL WACE, LLP (1.16M shares), PALISADE CAPITAL MANAGEMENT, LP (1.14M shares), OAK HILL ADVISORS LP (1.11M shares), and GOLDMAN SACHS GROUP INC (1.09M shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.